Econ-Omics Talks: Should we conduct genomic screening for all adults? Clinical and economic outcomes using simulation modeling

Professor Veenstra will present his research evaluating the benefits, risks, and costs of population-level genomic screening for adults. Drivers, barriers, and evidence gaps for both rare, high-risk genomic variants and more common moderate risk stratification approaches will be discussed. This presentation is part of the Econ-Omics Talks series and will include a brief speaker interview in addition to a research seminar.

Featured Speaker: Professor David Veenstra

David Veenstra is a Professor in the CHOICE Institute at the University of Washington in Seattle. His research focus is evaluating the clinical, economic, and policy implications of precision medicine. His major research projects include evaluation of the cost effectiveness of population-level genomic screening. Professor Veenstra teaches courses in health economics and managed care and is an author of five book chapters and 250 peer-reviewed publications.

Register here